Life Sciences Series B Founded 2017

JURA Bio

Developer of cell therapies for immunological disorders

📍 Boston, United States · Cell Therapy

jura.bio ↗

Funding snapshot

Last roundSeries B

Amount$16M

Date21 September 2023

About

Developer of cell therapies for immunological disorders. It offers a machine learning-guided RedPoint Design System for drug discovery that combines transformative MHC-CAR and cell-free systems for the development of autoimmune therapeutics.

Latest news

No articles yet.

Similar startups

LogixOne

Warehouse orchestration OS for mid-market brands shipping across India.

Enterprise Applications · Bengaluru, India

PhotoRoom

Application for product and portrait photography

High Tech · Paris, France

Aviso

AI powered predictive analytics platform

Enterprise Applications · Redwood City, United States

Immuneel

Developer of T-cell therapies for the treatment of cancer

Life Sciences · Bengaluru, India

Raising like JURA Bio?

Analyze your pitch deck before your next raise.

Analyze My Deck →